title: Illumina Spin-off to Develop Early-Detection Test.
abstract: DNA-sequencing giant Illumina has formed a new company, called Grail, to develop liquid biopsies capable of spotting cancer before symptoms arise. The start-up is working on a low-cost "pan-cancer" test that can detect multiple cancer types early, which it hopes to introduce by 2019.
authors.forename: Janet
authors.initials: J
authors.lastname: Colwell
mesh_terms: D001706:Biopsy / Q000191:economics / Q000379:methods*; D001709:Biotechnology / Q000458:organization & administration*; D055088:Early Detection of Cancer / Q000191:economics / Q000379:methods*; D006801:Humans